Zai Lab Limited (ZLAB) announced the pricing of its underwritten public offering of about 7.84 million American depositary shares, each representing ten ordinary shares of the Company, at a price of US$25.50 per ADS.
ZLAB closed Thursday's regular trading at $26.67 down $3.28 or 10.95%.
The gross proceeds to Zai Lab from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $200 million. The underwriters expect to deliver the ADSs against payment to the purchasers on or about November 18, 2024, on a "T+2" basis.
In addition, Zai Lab has granted the underwriters a 30-day option to purchase up to an additional 1.18 million ADSs at the public offering price, less underwriting discounts and commissions. Zai Lab intends to use the net proceeds from this offering for general corporate purposes.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.